Endoscopic Ultrasonography-guided Fine-needle Aspiration Cytology Combined with a Cell-block Method for Gastrointestinal Subepithelial Lesions

Objective The diagnostic accuracy of an endoscopic ultrasound-guided fine-needle aspiration cytology/biopsy combined with a cell-block method (FNA-CB) for gastrointestinal subepithelial lesions (GI-SELs) has not been fully studied. Methods A total of 109 patients (with 110 GI-SELs) were evaluated to clarify the rate of obtaining evaluable histology specimens using FNA-CB. In addition, we investigated the following: 1) the accuracy for determining the histology, 2) effects of the number of cell clusters obtained via FNA-CB, 3) correlation of the Ki67 labelling index (Ki67LI) of the gastrointestinal stromal tumor (GIST) lesions between FNA-CB and resected specimens, and 4) clinical courses for patients followed up after FNA-CB. Results Of the 110 GI-SELs for which FNA-CB was performed, 95 (86%) were able to be histologically evaluated using the first FNA-CB. For the 70 resected GI-SELs, the accuracy of FNA-CB to determine histology was 96%, remaining at 90% even when only a few cell clusters were obtained. The concordance rate of the risk-grouping of GIST (high-risk, Ki67LI ≥8; low-risk, <8) between FNA-CB and resected specimens was 84%. Of the 29 patients followed up after the first FNA-CB, 12 with benign GI-SELs determined using the first FNA-CB showed no obvious increases in their GI-SEL sizes. Conclusion Since FNA-CB can be used to determine the histology and reproductive activity of GI-SELs accurately, not only preoperative histological confirmation but also reliable information to determine clinical plans, such as follow-up without surgery or neoadjuvant chemotherapy, can be obtained.

[1]  Lian-song Ye,et al.  Clinical course of suspected small gastrointestinal stromal tumors in the stomach. , 2020, World journal of gastrointestinal surgery.

[2]  C. Lopes,et al.  Differential diagnosis of mesenchymal neoplasms of the digestive tract by cell block and immunohistochemistry , 2018, Cytopathology : official journal of the British Society for Clinical Cytology.

[3]  B. Nilsson,et al.  Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies , 2017, World journal of gastroenterology.

[4]  Yu Zhou,et al.  Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumors , 2017, Medicine.

[5]  M. Kida,et al.  Clinical implications of doubling time of gastrointestinal submucosal tumors , 2016, World journal of gastroenterology.

[6]  Wei-feng Chen,et al.  Diagnostic efficacy of endoscopic ultrasound-guided needle sampling for upper gastrointestinal subepithelial lesions: a meta-analysis , 2016, Surgical Endoscopy.

[7]  Y. Yatabe,et al.  Clinical course of gastrointestinal stromal tumor diagnosed by endoscopic ultrasound‐guided fine‐needle aspiration , 2015, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[8]  H. Cao,et al.  Prognostic value of Ki67 index in gastrointestinal stromal tumors. , 2014, International journal of clinical and experimental pathology.

[9]  Heikki Joensuu,et al.  Gastrointestinal stromal tumour , 2013, The Lancet.

[10]  M. Oikawa,et al.  PROSPECTIVE RANDOMIZED CONTROLLED STUDY COMPARING CELL BLOCK METHOD AND CONVENTIONAL SMEAR METHOD FOR PANCREATIC JUICE CYTOLOGY , 2012, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[11]  D. Hirasawa,et al.  Diagnostic efficacy of the cell block method in comparison with smear cytology of tissue samples obtained by endoscopic ultrasound-guided fine-needle aspiration , 2010, Journal of Gastroenterology.

[12]  F. Demichelis,et al.  Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours , 2008, BMC Cancer.

[13]  J. Lasota,et al.  Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. , 2009, Archives of pathology & laboratory medicine.

[14]  A. Yanagisawa,et al.  Intratumoral heterogeneity of MIB-1 labelling index in gastric gastrointestinal stromal tumor (GIST) , 2006, Gastric Cancer.

[15]  Y. Nakanishi,et al.  Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients , 2003, Gastric Cancer.

[16]  S. Hirohashi,et al.  Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. , 2002, Human pathology.

[17]  E. Narayan,et al.  Cell block cytology. Improved preparation and its efficacy in diagnostic cytology. , 2000, American journal of clinical pathology.